Advair HFA (fluticasone-salmeterol) prior authorization
Customize your policy alerts
Sign up for all careoregon policy alerts
Know when careoregon releases new policies or updates existing guidance.
Monitor payer policy activity
Defines prior authorization approval criteria for Advair HFA (fluticasone-salmeterol) for affected CareOregon members beginning 2026-07-01. Applies to medical/pharmacy benefit requests requiring prior authorization.
No material clinical or coverage changes in this revision.
Coverage Criteria for Advair HFA (fluticasone-salmeterol)
Approval Criteria
Covered when ANY of the following are met:
Advair HFA approval criteria
- Criterion 1: Member is 12 years of age or less
- Criterion 2: Submission of medical records (e.g., chart notes) confirming a medical reason generic Advair Diskus cannot be used
No other explicit exclusions are listed in the source prior authorization guideline for Advair HFA (fluticasone-salmeterol).
Coverage is not authorized when neither condition in the approval criteria is met — that is, when the member is older than 12 years and no medical records (e.g., chart notes) are submitted documenting a medical reason that generic Advair Diskus cannot be used.
Initial Therapy Conditions
Initial Therapy
Initial authorization conditions
Provider Actions, Documentation & Prior Authorization
Prior authorization required; approval = lifetime
Prior authorization is required for Advair HFA. Approvals are granted for the lifetime approval period ending 12/31/2039.
Document reason generic Advair Diskus is unsuitable
Provider must document why generic Advair Diskus cannot be used when requesting approval on that basis; no additional step therapy sequencing is specified in the policy.
Submit medical records when generic Advair Diskus is unsuitable
Submit supporting medical records (for example, chart notes) that confirm a medical reason why generic Advair Diskus cannot be used when relying on that criterion for approval.
- Examples: chart notes or other medical records documenting contraindication, intolerance, or other medical rationale
Denial risk if criteria not met
Coverage may be denied if the approval criteria are not met — specifically when the member is older than 12 years and no medical records are submitted demonstrating why generic Advair Diskus cannot be used.
Step Therapy / Substitution Requirements
| Requirement | Details |
|---|---|
| Provider must document why generic Advair Diskus is unsuitable when approval is sought on that basis. | Submission of medical records (e.g., chart notes) confirming medical reason generic Advair Diskus cannot be used is required. |
| When this documentation is used as the basis for approval, prior authorization will be granted per the policy's approval criteria (approval length: lifetime through 12/31/2039). | If documentation is not provided and the member is older than 12 years, coverage is not authorized. |
Definitions and Substitutions
Background
This document provides prior authorization criteria for Advair HFA (fluticasone-salmeterol). The approval criteria allow coverage if the member is 12 years of age or less or if the provider submits medical records (e.g., chart notes) confirming a medical reason generic Advair Diskus cannot be used. The guidance notes that age is coded to allow for pediatric use.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.